What You Should Know:
– Prominence Advisors, a leader in healthcare data enablement, has announced its acquisition of Tegra Analytics, a life sciences analytics consultancy. The acquisition extends Prominence’s data enablement platform into the life sciences sector, strengthening its services across providers, payers, and life sciences organizations.
– The acquistion will bring together expertise from both healthcare and life sciences, along with industry-leading customer service. The combined entity aims to unify healthcare and life sciences data, which will help accelerate insights.
Combining Expertise to Drive Performance and Innovation
Founded in 2002, Tegra Analytics has deep statistical expertise and extensive domain experience across the commercial and clinical lifecycles of pharmaceutical, biotech, and medical device organizations. The company is known for delivering highly customized analytical solutions, including innovative sales operations initiatives, robust data platforms, and advanced analytical support. Tegra helps life sciences companies operationalize data to drive performance and innovation.
By joining forces, Prominence gains immediate access to a robust portfolio of advanced analytics capabilities in the life sciences space. This will enhance its ability to serve pharmaceutical, biotech, and commercial organizations through an end-to-end data strategy.
“With Tegra Analytics, we’re expanding the reach of our data platform to unify healthcare and life sciences data – helping organizations accelerate discoveries, improve patient outcomes, and reduce costs,” said Bobby Bacci, CEO of Prominence Advisors.
Financial details of the acquisition were not disclosed.
